Efficacy of Daratumumab in Combination with Standard of Care Regimens in Lenalidomide-Exposed or -Refractory Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Analysis of the Castor, Pollux, and MMY1001 Studies
Year: 2018
Type: conference-abstract
Source: Blood
Authors: Saad Z. Usmani, Maria-Victoria Mateos, Suzanne Lentzsch, Hang Quach, Marcelo Capra, Roberto Ovilla, Jae-Cheol Jo, Ho-Jin Shin, Pieter Sonneveld, Ming Qi, Himal Amin, Jianping Wang, Xiang Qin, Linda Okonkwo, Jon Ukropec, Sonali Trivedi, Kenshi Suzuki, Meletios A Dimopoulos, Michele Cavo, Ajay K Nooka, Ajai Chari, Thierry Facon
Institutions: Levine Cancer Institute, Instituto de Investigación Biomédica de Salamanca, Columbia University Irving Medical Center, The University of Melbourne, St Vincent's Hospital Melbourne, Hospital Mãe de Deus, Ulsan University Hospital, Pusan National University Hospital, Erasmus MC, Janssen Research & Development (United States), Japanese Red Cross Medical Center, National and Kapodistrian University of Athens, University of Bologna, Emory University, Winship Cancer Institute, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Centre Hospitalier Universitaire de Lille
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2904818757